Abstract
Balanitis Xerotica Obliterans is a chronic, progressive, sclerosing inflammation of unclear etiology. It involves the external genitalia of males and more specifically the prepuce and its frenulum, the glans, and the external urethral meatus while it may extend to the peripheral part of the urethra. Recent studies have noted an increasing incidence in the paediatric population. It is the most common cause of secondary (pathologic) phimosis. Even more, in boys with physiologic phimosis that does not respond to conservative treatment, Balanitis Xerotica Obliterans should be considered as the underlying condition. In this study, we present all the latest data and attempt to create a diagnostic and curative algorithm regarding this condition.
Go to article
Bibliography
1. Hartley A., Ramanathan C., Siddiqui H.: The surgical treatment of Balanitis Xerotica Obliterans. Indian J Plast Surg. 2011 Jan; 44 (1): 91–97.
2. Depasquale I., Park A.J., Bracka A.: The treatment of balanitis xerotica obliterans. BJU International. 2000; 86 (4): 459–465.
3. Singh I., Ansari M.S.: Extensive Balanitis Xerotica Obliterans (BXO) involving the anterior urethra and scrotum. Int Urol Nephrol. 2006; 38: 505–506.
4. Hallopeau H.: Leçons cliniques sur les maladies cutanées et syphiliques. Union Med Can. 1887; 43: 472.
5. Depasquale I., Park A.J., Bracka A.: The treatment of Balanitis Xerotica obliterans. BJU Int 2000; 86: 459–465.
6. Catterall R.D., Oates J.K.: Treatment of Balanitis Xerotica obliterans with hydrocortisone injections. Br J Vener Dis. 1962; 38: 75–77.
7. Becker K.: Lichen Sclerosus in Boys. Dtsch Arztebl Int. 2011; 108 (4): 53–58.
8. Kizer W.S., Prarie T., Morey A.F.: Balanitis xerotica obliterans: Epidemiologic distribution in an equal access health care system. South Med J. 2003; 96: 9–11.
9. Jayakumar S., Antao B., Bevington O., Furness P., Ninan G.K.: Balanitis Xerotica obliterans in children and its incidence under the age of 5 years. J Ped Urol 2012; 8: 272–275.
10. Bochove-Overgaauw D., Gelders W., De Vyider A.: Rutine biopsies in pediatric circumcision (non) sense? J Pediatr Urol. 2009; 5: 178–180.
11. Pilatz A., Altinkilic B., Schormann E., et al.: Congenital phimosis in patients with and without lichen sclerosus: distinct expression patterns of tissue remodeling associated genes. J Uro. 2013; 189: 268e74.
12. Kizer W.S., Prarie T., Morey A.F.: Balanitis Xerotica Obliterans: epidemiologic distribution in an equal access health care system. South Med J. 2003; 96: 9e11.
13. Ebert A.K., Rösch W.H., Vogt T.: Safety and tolerability of adjuvant topical tacrolimus treatment in boys with lichen sclerosus: a prospective phase 2 study. Eur Urol. 2008; 54: 932e7.
14. Gargollo P., Kozakewich H., Bauer S., et al.: Balanitis Xerotica obliterans in boys. J Urol 2005; 174: 1409e12.
15. Kiss A., Csontai A., Pirot L., Nyirady P., Merksz M., Kiraly L.: The response of Balanitis Xerotica obliterans to local, steroid application compared with placebo in children. J Urol 2001; 165: 219e20.
16. Powell J., Wojnarowska F.: Lichen sclerosus. 1999; 353: 1777e89.
17. Peterson A.C., Palmineteri E., Lazzeri M., Guanzoni G., Barbagli G., Webster G.: Heroic measures may not always be justified in extensive urethral stricture due to lichen sclerosus (Balanitis Xerotica obliterans). J Urol. 2004; 64: 565–568.
18. Dillon W.I., Saeed G.M., Fivenson D.P.: Borrelia burgdorferi DNA is undetectable by polymerase chain reaction in skin lesions of morphoea, scleroderma or lichen sclerosus et atrophicus inpatients of North America. J Am AcadDermatol. 1995; 33: 617e20.
19. Pugliese J., Morey A., Peterson A.: Lichen sclerosus: review of the literature and current recommendations for management. J Urol. 2007; 178: 2268e76.
20. Meffert J.J., Davis B.M., Grimwood R.E.: Lichen sclerosus. J Am Acad Dermatol. 1995; 32: 393–416.
21. Powell J., Wojnarowska F.: Childhood vuvlvar lichen sclerosus: an increasingly common problem. J Am Acad Dermatol. 2001; 44: 803–806.
22. Depasquale I., Park A.J., Singh I., Ansari M.S.: Extensive Balanitis Xerotica Obliterans (BXO) involving the anterior urethra and scrotum. In Urol Nephrol. 2006; 38: 505–506.
23. Yardiey I.E., Cosgrove C., Lambert A.W.: Pediatric preputial pathology: are we circumcising enough? Ann R Coll Surg Engl. 2007; 89: 62–65.
24. Edmonds E., Barton G., Buisson S., et al.: Gene expression profiling in male genital lichen sclerosus. Int J ExpPathol. 2011; 92: 320e5.
25. Bale P.M., Lochhead A., Martin H.C., Gollow I.: Balanitis xerotica obliteransin children. Pediatr Pathol. 1987; 7: 617–627.
26. Mattioli G., Repetto P., Carlini C., Granata C., Gambini C., Jasonni V.: Lichen sclerosus et atrophicus in children with phimosis and hypospadias. Pediatr Surg Int. 2002; 18: 273e5.
27. Batbagli G., Palminteri E., Balo S., et al.: Lichen sclerosus of the male genitalia and urethral stricture diseases. Urol Int. 2004; 73: 1–5.
28. Celis S., Reed F., Murphy F., et al.: Balanitis xerotica obliteransin in children and adolescents: A literature review and clinical series. J Pediatr Urol. 2014; 10: 34–39.
29. Kiss A., Király L., Kutasy B., Merksz M.: High incidence of Balanitis Xerotica Obliterans in boys with phimosis: prospective 10-year study. Ped Dermatol. 2005; 22: 305–308.
30. Bale P.M., Lochhead A., Martin H.C., et al.: BXO in children Pediatr Pathol. 1987; 7: 617; 9.
31. Mohammed A., Shegil I.S., Christou D., Khan A., Barua J.M.: Paediatric Balanitis Xerotica obliterans: an 8-year experience. Arch Ital Urol Androl. 2012; 84: 12e6.
32. Vincent M., MacKinnon E.: The response of clinical Balanitis Xerotica Obliterans to the application of topical steroid-based creams. J Pediatr Surg. 2005; 40: 709e12.
33. Holbrook C., Tsang T.: Management of boys with abnormal appearance of meatus at circumcision for BXO. Ann R Coll Surg Engl. 2011; 93: 482–484.
34. Barbagli G., Palminteri E., Baló S., et al.: Lichen sclerosus of the male genitalia and urethral stricture deseases. Urol Int. 2004; 73: 1–5.
35. Pugliese J., Morey A., Peterson A.: Lichen sclerosus: review ofthe literature and current recommendations for management. J Urol. 2007; 178: 2268e76.
36. Nasca M.R., Innocenzi D., Micali G.: Penile cancer among patients with genital lichen sclerosus. J Am Acad Dermatol. 1999; 41: 911e4.
37. Pietrzak P., Hadway P., Corbishley C., Watkin N.: Is the association between Balanitis Xerotica Obliterans and penile carcinoma underestimated? BJU Int. 2006; 98: 74e6.
38. Prowse D.M., Ktori E.N., Chandrasekaran D., et al.: Human papillomavirus-associated increase in p16-INK4A expression in penile lichen sclerosus and squamous cell carcinoma. Br J Dermatol. 2008; 158: 261–265.
39. Neill S.M., Tatnall F.M., Cox N.H.: Guidelines for the management of lichen sclerosus. Br J Dermatol. 2002; 147: 640–649.
40. Poindexter G., Morrell D.S.: Anogenital pruritus: lichen sclerosus in children. Pediatr Ann. 2007; 36: 785–791.
Go to article
en
pl
